Podoplanin anticorps (FITC)
Aperçu rapide pour Podoplanin anticorps (FITC) (ABIN2853606)
Antigène
Voir toutes Podoplanin (PDPN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- This antibody reacts with mouse Aggrus/Podoplanin.
-
Purification
- Protein G agarose
-
Immunogène
- NL-17 cell membrane fraction
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS, 0.09 % NaN3, 1 % BSA
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8 °C.
-
-
- Podoplanin (PDPN)
-
Autre désignation
- Podoplanin
-
Sujet
- In addition to hemostasis and host defense, platelets are involved in the induction of inflammation, tissue repair, and tumor metastasis. Aggrus (T1α/Podoplanin) is a novel 36-45 kDa membrane sialoglycoprotein that induces platelet aggregation. Aggrus is highly expressed in various tumor cells and the platelet aggregation ability of Aggrus depends on specific oligosaccharide structures that may be related to the metastasis process in cancer cells. Aggrus has been identified as a diagnostic tumor marker for seminoma and testicular cancers.Synonyms: Aggrus, GP36, Glycoprotein 36, PA2.26 antigen, PDPN, PSEC0003, PSEC0025, T1-alpha
-
ID gène
- 10630
-
NCBI Accession
- NP_001006625
-
UniProt
- Q86YL7
-
Pathways
- Dicarboxylic Acid Transport
Antigène
-